Spravato (esketamine) — United Healthcare
Depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior
Initial criteria
- Diagnosis of major depressive disorder
- Patient is experiencing an acute suicidal ideation or behavior
- Provider and/or the provider’s healthcare setting is certified in the Spravato REMS program
Approval duration
12 months